Vaccine, Injection, M&A, Life Sciences, Covid-19

COVID-19 and the Life Sciences industry

8 Apr 2021

The COVID19 pandemic has dramatically impacted many aspects of life and will continue to do so at least for the better part of 2021. While the full extent of the effects still needs to be understood, many consequences can already be seen. Due to worldwide restrictions of elective procedures, healthcare providers suffered which will drive further consolidation of providers. The first months of 2020 saw an almost complete stop of M&A transactions, followed by an unexpected recovery of M&A activity in the second half. Governments across the world expanded their controlling power over M&A activity to secure medical resources. The German government e.g., has vetoed against non-EU bids for German manufacturers of vaccines, ventilators, protective equipment and other supplies of emergency and intensive care.

The acceleration of the digitalization due to the pandemic is expected to lead to more cross-sector deals. We have already seen large tech companies entering the Life Sciences space, now the pharmaceutical sector is acquiring digital companies to modernize their development processes. The social distancing rules during the pandemic led to a significantly improved acceptance of remote healthcare increasing the need for digital tools. COVID-19 has instantly changed consumer patients’ and consumer behavior towards accepting and adopting telemedicine.  Valuations for digital companies are expected therefore accepted to remain high.

Artificial Intelligence will play a major role in drug discovery and device development. While prior to 2020 concerns about data privacy have slowed down big data and AI driven business models, the pandemic accelerated this process. Pharma companies used AI to crunch clinical trial data to test whether their medicines are effective against COVID-19 and thus speeding up the approval process. AI is likely to revolutionize diagnostics by analyzing data generated by wearables and apps.

Long before the pandemic wearables have begun to play an increasing role in healthcare. Smart health products are now offering analytics way beyond the standard fitness trackers, including the detection of cardiac arrythmia and nocturnal breathing disorders. Wearables are becoming an important part of telemedicine, as they help to monitor patients remotely.

Disruptions of manufacturing processes and the supply chains have also impacted medical device and pharma industries. The pandemic has caused many players to re-evaluate their value chains. Closer proximity of suppliers, more flexibility and less dependence will lead to higher valuations for European contract manufacturers.

Government spending and market support measures of central banks to fight the economic recession has left financial markets with high liquidity pushing up asset prices in sectors which have shown to be resilient or even winners of the structural changes induced by the current crisis.

View full report here

 

 

Team

Picture of Jessica Algner
Jessica Algner

Assistant

Telefon: +49 30 809 33 47-12

LinkedIn

@

Picture of Polina Amini
Polina Amini

Senior Associate

Telefon: +49 40 300 836-14

LinkedIn

@

Picture of Jonatan Andersson
Jonatan Andersson

Equity Analyst

Telefon: +46 70 508 00 51

LinkedIn

@

Picture of Markus Augustsson
Markus Augustsson

Head of Equity Research

Telefon: +46 76 235 03 20

LinkedIn

@

Picture of Agata Barsallo
Agata Barsallo

Office Management & Accounting

Telefon: +44 20 8017 6020

@

Picture of Caroline Berglund
Caroline Berglund

Head of Equity Sales

Telefon: +46 73 382 10 82

LinkedIn

@

Picture of Anders Bo
Anders Bo

Managing Partner

Telefon: +45 4199 8252

LinkedIn

@

Picture of Ulf Boberg
Ulf Boberg

Senior Advisor Life Sciences

Telefon: +46 73 312 44 90

LinkedIn

@

Picture of Manfred Drax
Manfred Drax

Partner

Telefon: +49 89 255 49 53-15

LinkedIn

@

Picture of Anders Elgemyr
Anders Elgemyr

Managing Partner

Telefon: +46 70 496 18 15

LinkedIn

@

Picture of Niklas Elmhammer
Niklas Elmhammer

Senior Equity Analyst

Telefon: +46 898 39 59

LinkedIn

@

Picture of Sebastian Fischer
Sebastian Fischer

Director

Telefon: +49 89 255 49 53-12

LinkedIn

@

Picture of Daniel Garlipp
Daniel Garlipp

Managing Partner

Telefon: +49 40 300 836-19

LinkedIn

@

Picture of Philip Goldhahn
Philip Goldhahn

Vice President

Telefon: +49 40 300 836-21

LinkedIn

@

Picture of Thorsten Grandt
Thorsten Grandt

Vice President

Telefon: +49 30 809 33 47-20

LinkedIn

@

Picture of Johan Heigard
Johan Heigard

Vice President

Telefon: +46 70 246 99 88

LinkedIn

@

Picture of Caroline Heintz
Caroline Heintz

Senior Associate

Telefon: +46 707 40 68 58

@

Picture of Maurice Hinrichs
Maurice Hinrichs

Associate

Telefon: +49 40 300 836-20

LinkedIn

@

Picture of Arnold Holle
Arnold Holle

Managing Partner

Telefon: +44 20 80176020

LinkedIn

@

Picture of Lars Johansen
Lars Johansen

IT&Telecom Expert

@

Picture of Elaine Kelly
Elaine Kelly

Head of Marketing

Telefon: +49 40 300 836 18

LinkedIn

@

Picture of Anna-Lena Kickbusch
Anna-Lena Kickbusch

Office Management & Accounting

Telefon: +49 40 300 836 10

LinkedIn

@

Picture of Morten Kjærulff
Morten Kjærulff

Partner

Telefon: +45 2634 9031

LinkedIn

@

Picture of Mischa Krause
Mischa Krause

Director

Telefon: +49 40 300 836-24

LinkedIn

@

Picture of Steffen Leckert
Steffen Leckert

Managing Partner

Telefon: +49 89 255 49 53 26

LinkedIn

@

Picture of Malve Liebig
Malve Liebig

Senior Associate

Telefon: +49 89 255 49 53-18

LinkedIn

@

Picture of Erik Lundberg
Erik Lundberg

Partner

Telefon: +46 73 850 35 59

LinkedIn

@

Picture of Eva Macha
Eva Macha

Office Management & PA to Michael Moritz

Telefon: +49 30 809 33 47-10

LinkedIn

@

Picture of Mandy May
Mandy May

Head of Operations

Telefon: +49 30 809 33 47 16

LinkedIn

@

Picture of Mirja Meyer
Mirja Meyer

Office Management & Accounting

Telefon: +49 40 300 836 10

@

Picture of Mark Miller
Mark Miller

Managing Partner

Telefon: +49 40 300 836-11

LinkedInXING

@

Picture of Michael Moritz
Michael Moritz

Managing Partner

Telefon: +49 30 809 33 47-13

LinkedIn

@

Picture of Bertil Nilsson
Bertil Nilsson

Senior Equity Analyst

Telefon: +46 70 434 90 03

LinkedIn

@

Picture of Flemming C. Pedersen
Flemming C. Pedersen

Managing Partner

Telefon: +45 4199 8251

LinkedIn

@

Picture of Anika Schaefer
Anika Schaefer

Office Management & HR

Telefon: +49 89 255 495 310

@

Picture of Alexander Schleppegrel
Alexander Schleppegrel

Associate

Telefon: +45 2621 0543

LinkedIn

@

Picture of Nico Schmidt-Weidemann
Nico Schmidt-Weidemann

Managing Partner

Telefon: +49 89 255 49 53-17

@

Picture of Caspar Graf Stauffenberg
Caspar Graf Stauffenberg

Managing Partner

Telefon: +49 89 255 49 53-11

LinkedIn

@

Picture of Jon Tingling
Jon Tingling

Vice President

Telefon: +44 77 1347-8286

LinkedIn

@

Picture of Sybille de Vegvar
Sybille de Vegvar

Business Development & Marketing

Telefon: +44 20 8017 6017

@

Picture of Oskar Wollert
Oskar Wollert

Vice President

Telefon: +46 761 71 11 60

@

Picture of Jan-Frederik Zapp
Jan-Frederik Zapp

Associate

Telefon: +49 30 8093347-31

LinkedIn

@

Picture of Nils Zettelmeyer
Nils Zettelmeyer

Director

Telefon: +49 30 809 33 47-25

LinkedIn

@

Picture of Andreas Zetzsche
Andreas Zetzsche

Partner

Telefon: +49 30 809 3347 33

@

Picture of Marta Zientarski
Marta Zientarski

Vice President

Telefon: +46 73 840 55 66

@